Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mick

Showing results (51-60 of 122) with videos related to

Pageof 13
Sort By:
Ear and Hearing|January 27, 2017
Self-Adjustment of Upper Electrical Stimulation Levels in CI Programming and the Effect on Auditory FunctioningJantien L Vroegop, J Gertjan Dingemanse, Marc P van der Schroeff, et al.
Bone Marrow Transplantation|June 1, 1995
Source of stem cells impacts on hematopoietic recovery after high-dose chemotherapyT M Zimmerman, R Mick, S Myers, et al.
Journal of Applied Behavior Analysis|April 29, 2015
The value of choice as a reinforcer for typically developing childrenJulie A Ackerlund Brandt, Claudia L Dozier, Jessica Foster Juanico, et al.
Human Gene Therapy|December 28, 1999
Combined therapy with chemotherapeutic agents and herpes simplex virus type 1 ICP34.5 mutant (HSV-1716) in human non-small cell lung cancerT Toyoizumi, R Mick, A E Abbas, et al.
Leukemia|December 1, 1994
Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515H M Golomb, R Dodge, R Mick, et al.
Pharmacogenetics|February 1, 1996
Individualized dosing of amonafide based on a pharmacodynamic model incorporating acetylator phenotype and genderM J Ratain, R Mick, L Janisch, et al.
Cancer|October 1, 1994
Prognostic factors for survival in patients treated in phase I clinical trialsL Janisch, R Mick, R L Schilsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Pharmacokinetic and pharmacodynamic evaluation of the topoisomerase inhibitor irinotecan in cancer patientsE Gupta, R Mick, J Ramirez, et al.
Journal of the National Cancer Institute|June 3, 1992
Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancerE E Vokes, R R Weichselbaum, R Mick, et al.
Clinical Pharmacology and Therapeutics|November 1, 1991
Paradoxical relationship between acetylator phenotype and amonafide toxicityM J Ratain, R Mick, F Berezin, et al.
Pageof 13

Showing results (51-60 of 122) with videos related to

Sort By:
Pageof 13
Ear and Hearing|January 27, 2017
Self-Adjustment of Upper Electrical Stimulation Levels in CI Programming and the Effect on Auditory FunctioningJantien L Vroegop, J Gertjan Dingemanse, Marc P van der Schroeff, et al.
Bone Marrow Transplantation|June 1, 1995
Source of stem cells impacts on hematopoietic recovery after high-dose chemotherapyT M Zimmerman, R Mick, S Myers, et al.
Journal of Applied Behavior Analysis|April 29, 2015
The value of choice as a reinforcer for typically developing childrenJulie A Ackerlund Brandt, Claudia L Dozier, Jessica Foster Juanico, et al.
Human Gene Therapy|December 28, 1999
Combined therapy with chemotherapeutic agents and herpes simplex virus type 1 ICP34.5 mutant (HSV-1716) in human non-small cell lung cancerT Toyoizumi, R Mick, A E Abbas, et al.
Leukemia|December 1, 1994
Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515H M Golomb, R Dodge, R Mick, et al.
Pharmacogenetics|February 1, 1996
Individualized dosing of amonafide based on a pharmacodynamic model incorporating acetylator phenotype and genderM J Ratain, R Mick, L Janisch, et al.
Cancer|October 1, 1994
Prognostic factors for survival in patients treated in phase I clinical trialsL Janisch, R Mick, R L Schilsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Pharmacokinetic and pharmacodynamic evaluation of the topoisomerase inhibitor irinotecan in cancer patientsE Gupta, R Mick, J Ramirez, et al.
Journal of the National Cancer Institute|June 3, 1992
Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancerE E Vokes, R R Weichselbaum, R Mick, et al.
Clinical Pharmacology and Therapeutics|November 1, 1991
Paradoxical relationship between acetylator phenotype and amonafide toxicityM J Ratain, R Mick, F Berezin, et al.
Pageof 13